累及肾-肠系膜动脉的血管腔内主动脉修复术后1年死亡率的专用风险预测模型
基于血管外科学会血管质量倡议数据库中2012年1月至2023年8月择期复杂血管腔内主动脉修复术患者4053例,随机分为训练集3039例和验证集1014例,建立并内部验证1年死亡率的术前预测模型及简化评分系统,总体粗死亡率为11.3%(456/4053),低风险组1年死亡率为4%,高风险组为23%。
要点
- 总体粗1年死亡率为11.3%(456/4053),低风险组为4%,高风险组为23%。
- 独立术前预测因素包括慢性阻塞性肺疾病、慢性肾功能不全、血红蛋白<12 g/dL、体质指数降低、充血性心力衰竭、年龄增加、美国麻醉医师协会分级≥IV、当前吸烟、外周血管介入史和主动脉病变范围增加。
- 17%(679/3961)患者动脉瘤直径低于血管外科学会推荐治疗阈值,其中41%被归为中/高或高风险,该亚组院内并发症率18% vs 12%(P = .02),1年死亡率13% vs 5%(P < .0001)。
核心结论
- 该验证过的cEVAR术后1年死亡率术前预测模型纳入了生理、功能和解剖变量,简化评分系统可有效区分死亡风险,前瞻性应用时可能有助于改善术前决策、复杂动脉瘤诊疗和资源分配。
研究设计与样本
- 研究为预测模型推导与内部验证,纳入血管外科学会血管质量倡议数据库中2012年1月至2023年8月所有择期cEVAR(包括开窗、分支和/或烟囱技术),病变近端限于Ishimaru锚定区6至9。
- 患者共4053例,随机分为训练集3039例和验证集1014例。
- 采用逻辑回归模型预测1年死亡率,通过Bootstrap法对AUC及校准截距和斜率进行内部验证,并在验证集中预测1年死亡率。
- 根据模型β系数为独立预测因素分配整数评分,生成简化评分系统以对患者风险进行分类。
主要发现
- 择期cEVAR术后总体粗1年死亡率为11.3%(456/4053)。
- 1年死亡率的独立术前预测因素包括慢性阻塞性肺疾病、慢性肾功能不全(肌酐>1.8 mg/dL或依赖透析)、血红蛋白<12 g/dL、体质指数降低、充血性心力衰竭、年龄增加、美国麻醉医师协会分级≥IV、当前吸烟、外周血管介入史和主动脉病变范围增加。
- 1年死亡率从低风险组(占23%的患者)的4%到高风险组(占24%的患者)的23%不等。
- 模型在验证集中的表现与训练数据相当。
- 内部验证的评分系统将患者大致分为风险四分位数(低、低/中、中/高和高),52%的患者被归为中/高至高危,对应的1年死亡率分别为11%和23%。
关键数值与推荐
- 简化评分系统将患者分为低、低/中、中/高和高风险四个风险四分位数,低风险组1年死亡率为4%,高风险组为23%。
- 中/高和高风险组对应的1年死亡率分别为11%和23%。
- 动脉瘤直径低于血管外科学会推荐治疗阈值(女性<5.0 cm,男性<5.5 cm)的患者占17%(679/3961),其中41%被归为中/高或高风险。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Treatment goals of prophylactic endovascular aortic repair of complex aneurysms involving the renal-mesenteric arteries (complex endovascular aortic repair [cEVAR]) include achieving both technical success and long-term survival benefit. Mortality within the first year after cEVAR likely indicates treatment failure owing to associated costs and procedural complexity. Notably, no validated clinical decision aid tools exist that reliably predict mortality after cEVAR. The purpose of this study was to derive and validate a preoperative prediction model of 1-year mortality after elective cEVAR. METHODS: All elective cEVARs including fenestrated, branched, and/or chimney procedures for aortic disease extent confined proximally to Ishimaru landing zones 6 to 9 in the Society for Vascular Surgery Vascular Quality Initiative were identified (January 2012 to August 2023). Patients (n = 4053) were randomly divided into training (n = 3039) and validation (n = 1014) datasets. A logistic regression model for 1-year mortality was created and internally validated by bootstrapping the AUC and calibration intercept and slope, and by using the model to predict 1-year mortality in the validation dataset. Independent predictors were assigned an integer score, based on model beta-coefficients, to generate a simplified scoring system to categorize patient risk. RESULTS: The overall crude 1-year mortality rate after elective cEVAR was 11.3% (n = 456/4053). Independent preoperative predictors of 1-year mortality included chronic obstructive pulmonary disease, chronic renal insufficiency (creatinine >1.8 mg/dL or dialysis dependence), hemoglobin <12 g/dL, decreasing body mass index, congestive heart failure, increasing age, American Society of Anesthesiologists class ≥IV, current tobacco use, history of peripheral vascular intervention, and increasing extent of aortic disease. The 1-year mortality rate varied from 4% among the 23% of patients classified as low risk to 23% for the 24% classified as high risk. Performance of the model in validation was comparable with performance in the training data. The internally validated scoring system classified patients roughly into quartiles of risk (low, low/medium, medium/high and high), with 52% of patients categorized as medium/high to high risk, which had corresponding 1-year mortality rates of 11% and 23%, respectively. Aneurysm diameter was below Society for Vascular Surgery recommended treatment thresholds (<5.0 cm in females, <5.5 cm in males) in 17% of patients (n = 679/3961), 41% of whom were categorized as medium/high or high risk. This subgroup had significantly increased in-hospital complication rates (18% vs 12%; P = .02) and 1-year mortality (13% vs 5%; P < .0001) compared with patients in the low- or low/medium-risk groups with guideline-compliant aneurysm diameters (≥5.0 cm in females, ≥5.5 cm in males). CONCLUSIONS: This validated preoperative prediction model for 1-year mortality after cEVAR incorporates physiological, functional, and anatomical variables. This novel and simplified scoring system can effectively discriminate mortality risk and, when applied prospectively, may facilitate improved preoperative decision-making, complex aneurysm care delivery, and resource allocation.
引用
- Arnaoutakis DJ, Pavlock SM, Neal D, et al. A dedicated risk prediction model of 1-year mortality following endovascular aortic aneurysm repair involving the renal-mesenteric arteries. J Vasc Surg. 2023. PMID: 38070785. doi:10.1016/j.jvs.2023.12.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。